| | Other Issues: previous | next | latest | archiveEditorial “Review”-ing Our New Opportunities for “Rapid Report”-ing W. K. Alfred Yung PMCID: PMC2613812 Basic and Translational Investigations New therapeutic approach for brain tumors: Intranasal delivery of telomerase inhibitor GRN163 Rintaro Hashizume, Tomoko Ozawa, Sergei M. Gryaznov, Andrew W. Bollen, Kathleen R. Lamborn, William H. Frey, II, and Dennis F. Deen PMCID: PMC2613813 Malignant pineal germ-cell tumors: An analysis of cases from three tumor registries J. Lee Villano, Jennifer M. Propp, Kimberly R. Porter, Andrew K. Stewart, Tibor Valyi-Nagy, Xinyu Li, Herbert H. Engelhard, and Bridget J. McCarthy PMCID: PMC2613814 Identification of an alternatively spliced isoform of carbonic anhydrase XII in diffusely infiltrating astrocytic gliomas Joonas Haapasalo, Mika Hilvo, Kristiina Nordfors, Hannu Haapasalo, Seppo Parkkila, Alise Hyrskyluoto, Immo Rantala, Abdul Waheed, William S. Sly, Silvia Pastorekova, Jaromir Pastorek, and Anna-Kaisa Parkkila PMCID: PMC2613815 Tetramethylpyrazine inhibits activities of glioma cells and glutamate neuro-excitotoxicity: Potential therapeutic application for treatment of gliomas Yu-Show Fu, Yen-Yang Lin, Shih-Chich Chou, Tung-Hu Tsai, Lung-Sen Kao, Shao-Yun Hsu, Fu-Chou Cheng, Yang-Hsin Shih, Henrich Cheng, Yu-Yi Fu, and Jia-Yi Wang PMCID: PMC2613816 Convection-enhanced delivery of maghemite nanoparticles: Increased efficacy and MRI monitoring Benny Perlstein, Zvi Ram, Dianne Daniels, Aharon Ocherashvilli, Yiftach Roth, Shlomo Margel, and Yael Mardor PMCID: PMC2613817 Clinical Investigations Progression-free survival: An important end point in evaluating therapy for recurrent high-grade gliomas Kathleen R. Lamborn, W. K. Alfred Yung, Susan M. Chang, Patrick Y. Wen, Timothy F. Cloughesy, Lisa M. DeAngelis, H. Ian Robins, Frank S. Lieberman, Howard A. Fine, Karen L. Fink, Larry Junck, Lauren Abrey, Mark R. Gilbert, Minesh Mehta, John G. Kuhn, Kenneth D. Aldape, Janelle Hibberts, Pamela M. Peterson, Michael D. Prados, and North American Brain Tumor Consortium PMCID: PMC2613818 Evaluation and characterization of generalized anxiety and depression in patients with primary brain tumors Staci D. Arnold, Leslie M. Forman, Bart D. Brigidi, Karen E. Carter, Holly A. Schweitzer, Heather E. Quinn, A. Bebe Guill, James E. Herndon, II, and Renee H. Raynor PMCID: PMC2613819 A pilot study: 131I-Antitenascin monoclonal antibody 81c6 to deliver a 44-Gy resection cavity boost David A. Reardon, Michael R. Zalutsky, Gamal Akabani, R. Edward Coleman, Allan H. Friedman, James E. Herndon, II, Roger E. McLendon, Charles N. Pegram, Jennifer A. Quinn, Jeremy N. Rich, James J. Vredenburgh, Annick Desjardins, Sridharan Guruangan, Susan Boulton, Renee H. Raynor, Jeanette M. Dowell, Terence Z. Wong, Xiao-Guang Zhao, Henry S. Friedman, and Darell D. Bigner PMCID: PMC2613820 Effect of phenytoin on celecoxib pharmacokinetics in patients with glioblastoma Stuart A. Grossman, Jeffrey Olson, Tracy Batchelor, David Peereboom, Glenn Lesser, Serena Desideri, Xiaobu Ye, Tarek Hammour, Jeffrey G. Supko, and for the New Approaches to Brain Tumor Therapy CNS Consortium PMCID: PMC2613821 Brain and leptomeningeal metastases from cutaneous melanoma: Survival outcomes based on clinical features Jeffrey J. Raizer, Wen-Jen Hwu, Katherine S. Panageas, Andrew Wilton, Drew E. Baldwin, Elizabeth Bailey, Caroline von Althann, Lynne A. Lamb, Gladys Alvarado, Mark H. Bilsky, and Philip H. Gutin PMCID: PMC2613822 A multicenter phase II trial of intrathecal topotecan in patients with meningeal malignancies Morris D. Groves, Michael J. Glantz, Marc C. Chamberlain, Karen E. Baumgartner, Charles A. Conrad, Sigmund Hsu, Jeffrey S. Wefel, Mark R. Gilbert, Sandra Ictech, Kathy U. Hunter, Arthur D. Forman, Vinay K. Puduvalli, Howard Colman, Kenneth R. Hess, and W.K. Alfred Yung PMCID: PMC2613823 Phase II trial of irinotecan and thalidomide in adults with recurrent glioblastoma multiforme Vinay K. Puduvalli, Pierre Giglio, Morris D. Groves, Kenneth R. Hess, Mark R. Gilbert, Srikanth Mahankali, Edward F. Jackson, Victor A. Levin, Charles A. Conrad, Sigmund H. Hsu, Howard Colman, John F. de Groot, MeLesa G. Ritterhouse, Sandra E. Ictech, and W. K. Alfred Yung PMCID: PMC2613824 The utility of body FDG PET in staging primary central nervous system lymphoma Nimish A. Mohile, Lisa M. DeAngelis, and Lauren E. Abrey PMCID: PMC2613825 Society News Society News Oliver Bögler PMCID: PMC2613826 Call for Abstracts Neuro Oncol. 2008 April; 10(2): 232. PMCID: PMC2613828 Erratum Neuro Oncol. 2008 April; 10(2): 231. doi: 10.1215/15228517-2007-069.PMCID: PMC2613827 Corrects: Jie Li, et al. Identification of a novel proliferation-related protein, WHSC1 4a, in human gliomas. Neuro Oncol. 2008 January; 10(1): 45–51. |
